Journal
CANCER LETTERS
Volume 194, Issue 2, Pages 221-233Publisher
ELSEVIER SCI IRELAND LTD
DOI: 10.1016/S0304-3835(02)00709-7
Keywords
telomerase; human telomerase reverse transcriptase; human telomerase RNA component; biopsy; fine needle aspiration; cytology; telomeric repeat amplification protocol; diagnosis; prognosis; immunohistochemistry; tumor; cancer
Categories
Ask authors/readers for more resources
Telomerase, a critical enzyme responsible for continuous cell growth, is repressed in most somatic cells except proliferating progenitor cells and activated lymphocytes, and activated in approximately 85% of human cancer tissues. Telomerase activity is a useful cancer-cell detecting marker in some types of cancers in which almost all cases show telomerase activation. In other types in which telomerase becomes upregulated according to tumor progression, it is a useful prognostic indicator. Detection of human telomerase reverse transcriptase (hTERT) mRNA or protein in various clinical samples is also applicable. However, careful attention should be paid to the false negative results due to the instability of this enzyme or hTERT mRNA and the existence of polymerase chain reaction inhibitors as well as the false-positive results due to the contamination by normal cells with telomerase activity. If these pitfalls are avoided, in situ detection of hTERT mRNA or protein will facilitate the reliability of telomerase as a tumor marker. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available